Monoamine metabolites and neuropeptides in patients with Parkinson's disease, Huntington's chorea, Shy-Drager syndrome, and torsion dystonia.
Lindvall
B
B
Department of Neurology, University Hospital, Linköping, Sweden.
Olsson
J E
JE
D004422:Dystonia Musculorum Deformans / Q000134:cerebrospinal fluid*; D004744:Enkephalin, Methionine / Q000134:cerebrospinal fluid; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D006816:Huntington Disease / Q000134:cerebrospinal fluid*; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D007980:Levodopa / Q000008:administration & dosage; D008734:Methoxyhydroxyphenylglycol / Q000134:cerebrospinal fluid; D009479:Neuropeptides / Q000134:cerebrospinal fluid*; D018377:Neurotransmitter Agents / Q000134:cerebrospinal fluid*; D010300:Parkinson Disease / Q000134:cerebrospinal fluid* / Q000188:drug therapy; D012791:Shy-Drager Syndrome / Q000134:cerebrospinal fluid*; D013004:Somatostatin / Q000134:cerebrospinal fluid
D009479:Neuropeptides; D018377:Neurotransmitter Agents; D007980:Levodopa; D013004:Somatostatin; D008734:Methoxyhydroxyphenylglycol; D006897:Hydroxyindoleacetic Acid; D004744:Enkephalin, Methionine; D006719:Homovanillic Acid